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Detection and Assay of Mitochondrial Aspartate Aminottansferase in Serum
By T. R. C. BOYDE
Department of Clinical Biochemistry University of Newcastle ttpon Tyne
(Eingegangen am 30. April 1968)
A sensitive and specific clectrophorctic procedure is described for the assay of cationic aspartatc aminotransfcrasc in human scrum.
0.1 mil of cnaymic activity can be detected with case.
Normal scrum contains approximately 3 U//cationic isocnzyme. This can be identified unequivocally by the nc\v procedure, and confir-
matory experiments are described.
Für die Bestimmung der kanonischen Aspartattransaminase im Serum des Menschen wird eine empfindliche und spezifische clcktro-
phorctischc Methode beschrieben. 0,1 -mU können einfach nachgewiesen werden. Normnlscrum enthalt etwa 3 U// kanonisches Tsoenzym.
Dieses kann mit der angegebenen Methode eindeutig identifiziert werden. Versuche, die das bestätigen, werden beschrieben.
Aspartate aminotransfcrase (L-aspartate: 2-oxoglutarate
aminotransferase, EC 2. 6.1.1) comprises two iso-
en&ymcs. One is anionic, is associated with the soluble
fraction of the cell and ordinarily forms the bulk of the
scrum activity. The other is cationic, and is associated
with the mitochondria (1—7). Each may in turn be sub-
divisible (8—10), but it is unlikely that this will influence
the present results.
In suitable conditions of electrophoresis, the cationic
isoenfcyme is bound to a2-macroglobulin, and migrates
as a compact and sharply defined sone to a distinctive
position, "zone " (7). For present purposes, this
phenomenon is useful in that the activity is concentrated
into a small area, making detection more sensitive. The
physical basis and the specificity of this procedure have
been established by extensive experiments (7,12,13)
but it was not suspected that cationic aspartatc amino-
transferase might be present in normal scrum.
Tn developing a serum assay, sensitivity was further
increased by altering the substrate concentrations
towards the optima for cationic isoen^ymc (11), and by
reducing the amount of NADH used. As a result zone
II was now detected in normal serum specimens. This
paper describes the assay procedure and also the experi-
ments undertaken to confirm the nature of the observed
activity,
Materials and Reagents
Malatc dchydrogcnasc, NADH, and 2-oxoglutaric acid were
purchased from Boehringcr Corporation Ltd. Malatc dchydro-
genase was in the form of a suspension in 2.0w ammonium sul-
phate. The salt was removed by dialysing small portions, enough
for one week's work, against at least 500 volumes of 0.02M Tris-
acctatc buffer overnight at 4°. The volume doubled during this
process. 2-oxoglutaratc was prepared as a lOOmM solution, pH 7.4,
by titrating the acid with 2.ÖM NaOH, using a pH meter, and was
stored at 4° over chloroform.
i>aspartic acid was purchased ftrom Koch-Light Laboratories.
A I.OM stock solution pH 7.4 was prepared as for 2^-oxoglutarate,
and was stored at 4° over chloroform. Tris was purchased from
Sigma Chemical Co. ('Trizma base'). Acetic acid, boric acid,,
sodium hydroxide, and ammonium persulphate were obtained
from British Drug Houses Ltd., ('AnalaR* grade).
Tris-acotato buffer
A stock 0.2M solution was made by weighing out 0.165 mole
acetic acid, diluting this with water, dissolving in it 0.2 mole
'Tris' and making up to 1 /. Tin's gave a pH of 7.4 at the dilutions
used.
Dora/e buffer
A stock O.SM solution was prepared by dissolving 1.0 mole (61.8 g)
H3BO3 in 800 m/ water containing 0.17 mole NaOH, heating to
dissolve, and, when cool, diluting with water to 2.0 /. This kept
indefinitely in a polythene container. Dilution of 100 m/ to 2.0 /
gave the 25mM buffer, pH 8.4, used for electrophoresis.
Acrylamide and , '-mcthylcnc-bis-acrylamidc were supplied by
Koch-Light Laboratories. The dry powders were weighed out
in 95:5 ratio, thoroughly mixed in a pestle and mortar, and
stored in bulk in this form.
N,N,N\N'-Tctramcthylcthylcncdiaminc was supplied by Bastmnn-
Kodak. Agarosc was purchased from Hughes and Hughes (En-
zymes) Ltd. A 2% solution in water was prepared by heating on a
boiling water bath, and was kept in a scrcwcappcd jar.
Methods
Assay of total aspartatc amino t rans fc rase
The procedure (11) was modified from that of KARMHN (14) in
that tris-acctate buffer was substituted for phosphate, and the
L-aspartate concentration increased from 33mw to lOOnui. This
resulted in rates 25% greater than in the original procedure.
Temperature was controlled at 25°. For the purposes of this
paper, one unit (U) is the quantity of enzyme which is able to
convert 1 //mole of aspartate to oxaloacetate per in in under the
specified assay conditions (11).
Scmiquant i ta t ivc assay of cationic isocnzymc in s e r u m
Apparatus
The cJectrophorcsis tray was specially constructed of "Pcrspcx"
and had internal dimensions: — length 15.0cm (in the axis of
protein migration), width 20.0 cm. depth 0.75 cm. The cover was
made of "Perspcx" 0.3cm thick, 17.0cm long and 22cm wide,
and to this was glued an inner zone 0.15 cm deep, 14.9 cm long
and 19.9 cm wide, fitting snugly into the well of the tray, and
reducing the thickness of the gel itself to 0.6 cm. Insertion slot
formers, 20 in number, were glued to this inner zone in a single
row perpendicular to the direction of protein migration and
5.0 cm from one end. Each slot former was 0.15 cm thick (in the
direction of protein migration), 0.6 cm wide and 0.5 cm deep,
projecting down into the gel.
E/ectrapboresis procedure
To cast gel, 9.0 g of the acrylamide/bisacrylamide mixture plus
200 mg ammonium persulphate were dissolved in water to a
final volume of 200m/. Immediately before use, 0.2m/ tctra-
mcthylcthylcncdiaminc was addcd,thc whole thoroughly mixed and
poured carefully into the tray, set on a level surface. The cover
was now lowered gently into place, taking great care to extrude
air bubbles, and the slight excess of solution squeezed out by
placing weights of about 1 kg on top. After one hour (to ensure
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completion of the polymerisation reaction) the cover was gently
levered off.
Catalysts, and any unchanged monomer, were removed from the
gel by dialysis. The gel was freed from its tray by running a
spatula round the periphery and squirting a little water under-
neath, and was slid out into a larger, deeper tray"of 1 /'capacity.
The gels were too weak and slippery to handle.
Dialysis was with three changes of the electrophoretic buffer,
using about 700 m/ each time, leaving this in contact for 2 hours
with occasional agitation, and then removing the buffer by aspi-
ration. When dialysis was complete, the gel was returned to its
original tray, again by sliding it from one receptacle to the other.
With this relatively brief period of dialysis there was no appreciable
swelling of the gel.
Excess solution was swept off the surface of the gel with a plastic
batten (filter paper tended to adhere to the surface) and aspirated
from the sample slots with a Pasteur pipette.
The samples were applied in agarose gel to prevent electrodecan-
tation. A PASTEUR pipette was prepared with a stem of approxi-
mately 1.5 mm diameter having a tip of approximately 0.3 mm
diameter, and marks were made indicating volumes of 15 μΐ and
75 μ/. A small portion of the 2% agarose solution was melted
down in a boiling water-bath. Molten agarose was drawn up to
the first mark on the PASTEUR pipette, and, after wiping the
pipette, the sample was drawn up to the second mark. The cpntents
of the pipette were then expelled into one of the depressions of
an immunological dimple tray, mixed rapidly by drawing up and
expelling several times, and then transferred to the sample slot,
which was filled flush with the surface of the gel. The pipette was
rinsed with warm (40°) saline and then with boiling water before
repeating the cycle of operations with subsequent samples.
Agarose -tending to set in the pipette was removed by rinsing in
boiling water. Such blockages occurred most frequently in the
narrow outlet.of the pipette, but this feature was highly desirable
because it helped in controlling the column of fluid in the stem of
the pipette and in delivery to the sample slot. Bubbles were
carefully avoided.
The agarose, when first taken up into the pipette, was of course at
about 100°, but cooled rapidly, so that denaturation of protein in
the sample was considered unlikely.
Electrophoresis was carried out in the horizontal position, in a
cold room at 4°, overnight (16h) at 2.0 V/cm, the tray resting on
the edges of the buffer tanks and making contact through buffer-
soaked cloth wicks, 10 cm by 20 cm. The buffer tanks were
large (2 / capacity) and over 20 cm wide since electrophoresis was
in the short (15.0 cm) axis of the gel. The tanks used were fitted
with platinum electrodes. If runs were being done on successive
nights, it was possible to economise in the use of buffer by re-
versing the polarity of the electrodes each night, but buffer was
never kept longer than 4 days. A 120 V dry battery was used to
provide the potential for electrophoresis, giving 20 V measured
at points 10 cm apart on the gel surface. The commonest difficulty
experienced was too low conductivity in the cloth wicks, and it
was found desirable to use at least 6 layers of cotton shirt material.
The central portion of the gel was covered with polythene film
to prevent evaporation.
Defection and Assay Procedure
When electrophoresis was complete, the gel was placed in an
incubator at 37° whilst other preparations were made.
A portion of the stock 2% agarose solution was melted down in
a boiling water-bath, then briefly cooled in a water-bath at about
40°. Meanwhile, in another test-tube, a mixture was made up
containing aminotransferase substrates, malate dehydrogenase,
NADH and buffer. This was warmed to 40° in the same water-
bath as above. After 20 min. in the 37° incubator the gel was
placed on an absolutely level surface, and one corner covered
with a square piece of "Perspex" 2.5 by 2.5 by 0.6 cm, to provide a
control area of gel free from NADH fluorescence. The agarose
solution and substrate solution were mixed, the mixture poured
over the surface of the gel, and quickly spread with a glass rod. If
Composition of Detection Mixture
Reagent
Agarose 2 %
L-aspartate
2-oxoglutarate
Tris-acetate buffer
MDH (Dialysed)
NADH
Quantity
4g
1.0 mi of l.OM soln.
10 ml of 0.1 M soln.
5 ml of 0.2M soln.
0.5m/
3mg
Initial
concn. in
agarose
soln.
49mM
49mM
• 49mM
Final concn.
in gel
(assuming
equilibrium
diffusion
where
appropriate)
5mM
5mM
5mM
0.015 /imoles
per cm2 gel
area
the'gel was cold, over-rapid setting of the agarose sometimes
prevented the formation of a thin, even layer.
The preparation was left undisturbed until the agar layer was
thoroughly set (10 min.), then, after removing the 2.5 by 2.5 cm
"Perspex" square, it was transferred again to the 37° incubator.
At intervals, the gel was taken to a photographic dark room for
inspection under ultra violet light.
The lamp used was a Philips 125 W MBW/U bulb (requiring a
choke and capacitor), mounted in a 3-pin ceramic holder which
serve'd also as" a" handle. This was switched on* 10 miri. before the
first inspection, and left on throughout the .period of the experi-
ment, supported above the bench by a laboratory clamp, gripping
the holder. Shielding was considered unnecessary as the glass
envelope was found to be an adequate protection against dange-
rous short wavelength radiation. For inspection, the electro-
phoresis tray was placed on a sheet of black paper, and the lamp
brought, by hand, close'to the surface of. the gel. The dark room
lights were, of course, switched off during the inspection. To
obtain quantitative results, it was necessary to employ standard
times of inspection, namely 15, 30, 60, 100, 150, and 240 min.
after application of the agar layer.
The 2.5 by 2.5 cm "Perspex" square served" to exclude the sub-
strate-containing agar layer from one corner of .the gel. This
area appeared dark because of the absence of NADH fluorescence
and served as a standard against which dark zones resulting from
enzymic oxidation of the nucleotide could be gauged. At each
inspection, the region between 1.0 and 2.0 cm on the anode side
of the origin slots was carefully scanned for dark spots. The
position and shape of "zone II" bands was quite distinctive.
Grades F to A were allotted according to the inspection at which
a distinct zone could first be made out: —15 min., grade F, ap-
proximately 35 U// cationic isoenzyme; 30 min., grade E, approxi-
mately 19 U//; 60 min., grade D, 11 U//; 100 min., grade C, 7 U//;
150min., grade B, 5 U//; 240 min., grade A (normal), 3 U//.
Incubation was not normally prolonged beyond 240 min., but
for grades F to B an additional criterion was used — that by the
next inspection after allotting a grade the zone should have
progressed to become as dark as the standard (NADH-free)
area. If this did not occur, the grading was revised to read one
lower (e. g. grade D for grade E, etc.). This system of grading,
and the approximate activities given above, apply only to zone II,
and hence only to the cationic isoenzyme. Clearly, the method
must be regarded as only .^/-quantitative. The equivalent acti-
vities given above for each grade are" based on calibration ex-
periments exemplified by figure 1, and upon evidence that the
true normal level is 3 // (see below). ·
Photographic recording of the patterns (when necessary) was by
fluorescent light using f 2.8, Kodak Panatomic X film and a
Kodak No. 61 filter over the camera lens (12). The source of
exciting light was the MBW/U bulb described above, which was
moved to and fro about 25 cm from the gel surface throughout
an exposure period of 2 min.
Separation of macroglobulin — bound enzyme by gel
filtration chromatography
The column used, the Sephadex G150, and the procedure in
general were as described elsewhere (7). The column was equili-
brated with 25 mM borate buffer, pH 8.4.
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30 mm 150 min
60 min 240 min
100 min
Fig. l
Calibration of the method for semiquantitative assay of cationic
aspartate aminotransferase. Successive photographs of a single gel by
fluorescent light
Preparation of gel, electrophoresis, and procedure for detection of
enzyme activity were as described in the text.
The samples were prepared as follows. To 1.0m/ of normal serum
was added a preparation (11) of cationic isoenzyme, containing in
5 μ/, lOOmU enzyme activity. A portion of this mixture was diluted
further .with 2 volumes of normal serum, to give a serum containing
approximately 32 U// added cationic isoenzyme. Using this as the
starting point, a series of doubling dilutions was made in serum.
It is assumed that normal serum contains 3 U// cationic isoenzyme.
Track No.
1
3
5
7
9
11
13
15
17
18
19
20
Grade
FΕ
D
C
B
A
A
A
A
Cationic
isoenzyme
added, U//
32
16
8
4
2
0.5
1.0
0.25
=
Total, υ/1
35
19
11
7
5
3.5
4.0
3.25
Normal serum (J.
Normal serum (A.
Normal serum (S.
Normal serum (A.
H. D.)
H.)
A. S.)
W. S.)
Tracks count from left to right. The gel is arranged anode end upper-
most. The time at which each photograph was taken is given in the
figure, together with the lowest grade of activity accepted by the
criteria given in the text.
Only zone II activities (indicated by arrow) are considered. The
photographs show somewhat more contrast then was appreciable
with the naked eye. It will be noted that the sample in track 13,
containing 1.0 U// added cationic isoenzyme, gives a distinctly darker
zone II that does normal serum, whereas that in track 11, containing
0.5 U// added cationic isoenzyme, is scarcely distinguishable from
normal. Clinical samples resembling that in track 13 have given rise
to difficulty in grading and have been accorded an intermediate
grade, A—B.
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15 m/ of normal human serum was dialysed overnight against
this buffer, applied to the column (760 ml bed volume), eluted
with the same buffer at 12 m//h and collected as 10 ml fractions.
Fractions 18—28 were combined and concentrated to 3.4 ml by
ultrafiltration.
Collection of blood. Preparation of serum and plasma
Blood was collected by venepuncture, avoiding stasis and turbulent
flow, using stainless steel needles and all-glass syringes lubricated
with a silicone preparation. Each specimen was divided between
two polyvinyl chloride specimen tubes (Stayne Laboratories
Ltd), one without anticoagulant and one containing dry heparin.
The latter was mixed gently by inversion and immediately centri-
fuged at 3000 rev./min. in an M.S.E. "Minor" centrifuge for
20 min/ The topmost layer of plasma was removed at once by
means of a PASTEUR pipette and stored in a polyvinyl chloride
tube until required for use later the same day. The sample without
anticoagulant was allowed to clot and separate at room tempe-
rature for 2 h, then the serum separated by brief centrifugation.
Results
The appearance of zone II in normal serum specimens
is illustrated in tracks 17—20, figure 1.
In experiments using the same set of normal serum
specimens on each of three gels, run and tested simulta-
neously, it was observed that if either L-aspartate or
2-oxoglutarate were omitted from the detection mixture,
none of the enzyme zones appeared. This indicates that
all the zones which can be visualized by the present
technique, including zone II, are due only to the activity
of aspartate aminotransferase.
There was no difference in zone II activity between
serum and plasma prepared simultaneously from the
same blood samples from normal individuals.
Identification of isoenzyme responsible for %pne II
The serum macroglobulin concentrate (for preparation,
see above) was tested by the electrophoretic assay
procedure. No activity appeared in the zone I area. The
zone II activity was grade D — equivalent to 2:5 U//
cationic isoenzyme in the original serum specimen after
allowance has been made for the volume reduction by
ultrafiltration.
0.5 m/aliquots of the serum macroglobulin concentrate
were subjected to differential assay by the procedure of
FLEISHER, POTTER and WAKIM (1). The ratio, (Rate at
pH 6.0)/(Rate at pH 7.4), was found to be 0.405.
Purified preparations of the isoenzymes from human
liver (11) were tested at the same time. The ratios ob-
tained were, cationic isoenzyme, 0.36, anionic isoenzyme,
0.03.
Normal serum level of cationic isoenzyme
Direct assay of the serum macroglobulin concentrate
gave 15.2 U// — equivalent to 3.4 U// in the original
serum specimen. This may be compared with the figure
of 2.5 U// suggested by the electrophoretic assay proce-
dure. Having regard to the potential sources of error in
these two determinations, it is suggested that the normal
level should be accepted as approximately 3 U//. By the
present technique, all normal serum samples are indis-
tinguishable in regard to their zone II activity.
Discussion
It is shown above that cationic aspartate aminotrans-
ferase is a normal constituent of plasma. Although
leucocytes contain cationic isoenzyme (15), the activity
observed in normal serum originates elsewhere.
Most other workers have been unable to detect the
cationic isoenzyme in normal serum (2,16—20), pre-
sumably because their methods of assay were insufficient-
ly sensitive.
FLEISHER'S group (2,21) injected cationic isoenzyme
into dogs, intravenously, and found that it was cleared
rapidly and completely. This observation has been used
to explain the seeming absence of the isoenzyme from
normal serum and its transient appearance in disease
(2,16,17). Plainly it is necessary to reinyestigate the
plasma levels in disease, using a more sensitive method
of assay than heretofore. Clinical results with the present
method will be reported separately (22).
NOTARBARTOLO and coworkers (23) have recently
reported finding 3^1 (mean ± standard deviation)
U// cationic isoenzyme in normal serum — in agree-
ment with the present results. It is not clear, however,
how the Italian workers excluded interference from
anionic isoenzyme. ROTZSCH (24) has employed a tech-
nique involving cellulose acetate electrophoresis and
elution prior to assay by the method of REITMAN and
FRANKEL (25). He reported finding cationic isoenzyme
activity equivalent to 7 U// in normal serum. If an
appropriate allowance is made for the serious under-
estimation of cationic isoenzyme by the REITMAN and
FRANKEL method (5, 12), the result would be much
higher still, but even as it stands the figure is so high as
to cast doubt on the specificity of the overall procedure.
According to the present procedure, all normal sera are
indistinguishable. It is, of course, improbable that the
normal level is so little variable as this would suggest. If
small variations about the norm are clinically significant,
a very precise and specific quantitative assay will be
required. This has not yet been achieved.
There is a possibility of making this or related methods
truly quantitative. One might arrange for fluorescence
scanning of the finished gel. Alternatively one might
cut out the "slow a2"-zone and assay the activity in
this region (12).
The present procedure can be used to measure cationic
isoenzyme otherwise than in serum, if a source of
a2-macroglobulin is provided.
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Untersuchungen über das Schicksal
von Dextran im Organismus von Meerschweinchen
Von K. H. EBERT, G. SCHENK^) und R. ScHOLZ2)
Institut für Technische Chemie der Technischen Hochschule München
(Eingegangen am 7. Mai 1968)
Nach einmaliger Injektion von tritiierten Dextranfraktionen mit unterschiedlichen, genau definierten Molekulargewichten, wurde an
Meerschweinchen die Verweildauer des Dextrans im Blut, seine Ausscheidung, Metabolisierung und Retention in den Geweben unter-
sucht. Nahezu 100% der injizierten Tritiumaktivitäten konnten im Blut, in den verschiedenen Organen und in den Ausscheidungs-
produkten wiedergefunden werden. Die Verweildauer im Blut und die Ausscheidung über Nieren und Darm zeigen eine hohe Abhängig-
keit vom Molekulargewicht des injizierten Dextrans. Eine Ausscheidungsschwelle scheint in den Nieren für Molekulargewichte über
50000 zu bestehen. Die Bildung von Tritiumwasser bestätigt, daß die Dextrane abgebaut und in den intermediären Stoff-
wechsel eingeschleust werden. Diese Abbaureaktionen zeigen eine molekulargewichtsabhängige Induktionsperiode von ein bis drei
Tagen. Niedermolekulare Fraktionen werden bedeutend schneller umgesetzt als höhermolekulare. Dextran wird in den meisten Organen
retiniert, wobei hinsichtlich des Ausmaßes dieser Retention folgende Reihenfolge aufgestellt werden kann: Milz, Haut, Lunge, Leber,
Niere, Fettgewebe, Skelettmuskulatur. Im Gehirn sind nur Spuren nachweisbar. Mit Ausnahme der Milz ist in den meisten Organen die
Dextranretention nur angedeutet molekulargewichtsabhängig. Die Verweildauer der Dextrane im Blut wird vorwiegend von der Aus-
scheidung über die Nieren bestimmt, Metabolisierung oder Retention in den Geweben haben dagegen keinen wesentlichen Einfluß. Das
Verhalten der Milz zeigt jedoch, daß dem reticuloendothelialen System eine bedeutende Rolle bei der Reinigung des Blutes von höher-
molekularen Dextranen zukommt.
Studies on the fate of injected dextran in the guinea pig
Guinea pigs were given single injections of tritiated dextran fractions of different and precisely known molecular weights. The persistence
of dextran in the blood, its excretion, metabolism and retention in the tissues were studied. Practically 100% of the injected tritium
activity was found in the blood, various organs and excretory products. The persistence of the dextran in the blood and its excretion via
the kidneys and intestine showed a marked dependence on the molecular weight. There appears to be an excretory threshold in the kidneys
for molecular weights above 50000. The appearance of tritium water showed that the dextrans are degraded and thereby become
involved in intermediary metabolism. These degradation reactions are subject to an induction period of one to three days, depending on
the molecular weight of the dextran. Low molecular weight fractions are degraded significantly more rapidly than high molecular weight
fractions. Dextran is retained by most organs to an extent represented by the following order: spleen, skin, lungs, liver, kidneys, adipose
tissue, skeletal muscle, and only a trace in the brain. With the exception of the spleen, the retention of dextran in most organs is only
slightly affected by molecular weight. The persistence of dextrans in the blood is determined chiefly by the excretion via the kidneys, and
the metabolism or retention in the tissues have essentially no effect. The behaviour of the spleen shows, however, that the reticuloendo-
thelial system plays a significant part in the purification of the blood by the removal of high molecular weight dextrans.
*) derzeitige Adresse: Knoll AG, Chemische Fabriken, 67 Ludwigshafen a. Rh.
2) z. Z. Johnson Research Foundation, School of Medicine, University of Pennsylvania, Philadelphia/USA.
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